In a 2018 mouse study of ulcerative colitis, oral KPV reduced intestinal inflammation by 72%—comparable to the steroid prednisolone—without immunosuppressive side effects. The secret lies in its dual action: blocking NF-κB while boosting protective Treg cells.
What Is KPV?
Derived from the C-terminal fragment of α-MSH, KPV (Lys-Pro-Val) is one of the smallest bioactive peptides at just three amino acids. Researchers at the University of Florence discovered its anti-inflammatory properties in the 1990s while studying melanocortin signaling. Unlike full-length α-MSH (13 amino acids), KPV lacks hormonal activity but retains key receptor interactions.
Mechanism of Action
NF-κB Inhibition
KPV binds to MC1R and MC3R on immune cells, suppressing the NF-κB pathway. This blocks production of:
TNF-α
IL-6
IL-1β
Treg Activation
Simultaneously, KPV increases Foxp3+ regulatory T cells by 40-60% in gut-associated lymphoid tissue (GALT), creating localized immune tolerance.
Research Highlights
| Condition | Model | Dose | Duration | Result |
|---|---|---|---|---|
| Colitis | Mice (n=12/group) | 2 mg/kg oral | 7 days | 72%↓ inflammation vs control |
| Dermatitis | Human keratinocytes | 10 μM topical | 48h | IL-8 reduced by 65% |
| Sepsis | Rat (n=8/group) | 1 mg/kg IV | 24h | 58%↓ mortality rate |
Dosing Protocols
| Goal | Route | Dose | Frequency | Cycle |
|---|---|---|---|---|
| Gut inflammation | Oral | 1-2 mg/kg | 2x daily | 2-4 weeks |
| Skin conditions | Topical | 0.1-0.5% cream | Daily | As needed |
| Systemic support | SubQ | 100-200 mcg/kg | 3x weekly | 3 weeks |
Safety & Side Effects
No serious adverse events reported in studies
Theoretical risk of immunosuppression with prolonged high doses
Contraindicated with concurrent immunosuppressive drugs
How It Stacks
Pairs with **BPC-157** for gut healing (KPV reduces inflammation while BPC stimulates repair — explore third-party tested BPC-157 from trusted suppliers) or **Thymosin Alpha-1** for immune modulation (KPV targets innate immunity, TA1 boosts adaptive — compare Thymosin Alpha-1 pricing from verified vendors).
Key Takeaways
KPV is the smallest clinically studied anti-inflammatory peptide
Works via MC receptors without hormonal effects
Oral bioavailability unique among peptides — lab-tested KPV is available from verified research suppliers
Human safety data limited but promising
Dosing varies widely by application (topical vs systemic)
Combine with growth factors for tissue repair
---
---
Continue Your Peptide Research
🔬 Explore our peptide database — Browse 500+ research peptide profiles with mechanisms of action, dosing protocols, and clinical evidence summaries.
🤖 Have questions? — Ask PeptideAI, our research assistant, for personalized peptide guidance based on the latest studies.
📚 Want more guides? — Browse all research articles covering peptide science, comparisons, and buying guides.
Related Articles on BuyPeptidesOnline.com
Continue your research with these in-depth guides:
